Stock listing
Tyra Biosciences, Inc.
Selected listing: TYRA · NASDAQ · USD · US
Tyra Biosciences, Inc. (NASDAQ:TYRA), Health Technology. Latest release Sep 14, 2026: Tyra Announces Pricing of $400 Million Underwritten Offering of Common…
- Ticker
- NASDAQ:TYRA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Tyra Biosciences, Inc.
The company focuses on developing innovative therapies for cancer treatment. Tyra aims to address unmet medical needs through its research and development efforts.
Latest news from Tyra Biosciences, Inc.
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
September 14, 2026
Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
September 9, 2026
Tyra Biosciences to Present at the Cantor Global Healthcare Conference
September 8, 2026
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
September 4, 2026
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
August 4, 2026
Research Tyra Biosciences, Inc.
Tyra Biosciences, Inc. company profile
View the public company page for Tyra Biosciences, Inc. on 6ix.
Tyra Biosciences, Inc. news
Read company news and market updates connected to Tyra Biosciences, Inc..
Tyra Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Tyra Biosciences, Inc..